Almost eight months after the White House first announced it would move from containment to mitigation efforts to stop the spread of the COVID-19 epidemic, the Administration is now pinning its hopes on vaccines to inoculate the population and therapies to treat the disease. Months after announcing it would be working with technology giants Apple and Google on a contact tracing app (and nearly two months after Google and Apple rolled out their exposure notification features) and initiating wide spread testing efforts nationwide with the largest national pharmacies (which never received the coordinated support it needed), the Administration appears to be giving up on a national effort to stop the spread of the COVID-19 epidemic. US response to the COVID-19 coronavirus moves from ‘containment’ to ‘mitigation’ In an interview with CNN’s Jake Tapper White House Chief of Staff Mark Meadows said that the US is “not going to control the pandemic… We are gonna control the fact that we get vaccines, therapeutics and other mitigation.” MEADOWS: We're not going to control the pandemic TAPPER: Why not? M: Because it's a contagious virus T: Why not make efforts to contain it? M: What we need to do is make sure we have the proper mitigation factors to make sure people don't die pic.twitter.com/0DYgk4rB3T — Aaron Rupar (@atrupar) October 25, 2020 The admission is a final nail in the coffin for a federal response that could have involved a return to lockdowns to stop the spread of the virus, or national testing and contact tracing and other mitigation measures.
The Us Now Seems To Be Pinning All Of Its Hopes On Covid-19 Therapies And Vaccines
Jonathan Shieber, TechCrunch
Sun, 10/25/2020 - 12:23pm
Topics: months apple cnn s jake tapper white house chief staff mark meadows meadows tapper aaron rupar atrupar october january scott gottlieb md scottgottliebmd october novavax johnson moderna therapeutics pfizer uk in china sinopharm yorker sinovac bangladesh indonesia cansino biologics july university oxford european astrazeneca india united kingdom south africa murdoch children s research institute gamaleya national center epidemiology microbiology russian direct investment fund world health organization therapies the milken institute antibody rna-based u.k china italy russia the us president s fda us-based adaptive biotechnologies cytovia therapeutics sab biotherapeutics applied therapeutics partner therapeutics sarepta therapeutics united states army medical research institute infectious diseases at u.s carbon health eran bali techcrunch s disrupt this nobel prize-winning jennifer doudna us white house covid-19 google covid tapper a at johnson chinese brazil australia finally japan president united states crispr pinning hopes vaccines treatments spread stop trials phase mitigation patients companies clinical company pharmaceutical developed working infection cases cells testing drug ways epidemic bacteria efforts technology treat ability treatment government people approval control viral startups emergency federal consumers compounds blood reduce deaths widespread lung recovered containment antivirals cell-based replicate infected existing boost response received pandemic tracing approved attacking system program approvals action prevent contact repurposing regulatory finding authorizations won natural recruiting administration signal large doesn private developing
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more